KRAS mutant colon cancer | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

96,236 results for “KRAS mutant colon cancer”

colon cancer therapy (NCI)

Pooled mutant-KRAS peptide vaccine (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

mRNA vaccine targeting KRAS mutant antigens (cancer)

siRNA agent (colon cancer)

Mutant KRAS Inhibitors (solid tumor)

Mutant KRAS G12V-specific TCR tranduced autologous T cell therapy (Changhai Hospital of Shanghai)

SOS1 / KRAS (KRAS -driven cancer)

KRAS-mutant Tumor(Ionova Life Science)

Investigational

Sotorasib(Lumakras, Lumykras)

Conditions: Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

C₃₀H₃₀F₂N₆O₃

multi-KRAS inhibitor (cancer)

Page 1 of 254